title: Cancer after heart transplant: implications for practice.
abstract: Cancer after heart transplant is recognized as a leading cause of morbidity and mortality. A man's clinical course after receiving a heart transplant is described, with emphasis on important clinical considerations in the care of heart transplant recipients.
authors.affiliation: Mayo Clinic, Rochester, MN, USA. wagner.jean2@mayo.edu
authors.forename: Jean A
authors.initials: JA
authors.lastname: Wagner
mesh_terms: D001379:Azathioprine / Q000008:administration & dosage; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D005938:Glucocorticoids / Q000008:administration & dosage; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D016030:Kidney Transplantation; D008175:Lung Neoplasms / Q000473:pathology* / Q000628:therapy; D008297:Male; D008479:Mediastinal Neoplasms / Q000473:pathology* / Q000601:surgery; D008875:Middle Aged; D009173:Mycophenolic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives; D009364:Neoplasm Recurrence, Local; D010997:Pleural Neoplasms / Q000473:pathology* / Q000628:therapy; D011241:Prednisone / Q000008:administration & dosage; D020123:Sirolimus / Q000008:administration & dosage; D012878:Skin Neoplasms / Q000473:pathology*; D016559:Tacrolimus / Q000008:administration & dosage
chemical_list: D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D001379:Azathioprine; D011241:Prednisone; D020123:Sirolimus; D016559:Tacrolimus